Regeneron AA Multicenter (Dupilumab)

Clinical trial NCT05551793 · RECRUITING

Trial details

NCT number: NCT05551793
Sponsor: Emma Guttman
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alopecia Areata

Start date: 2023-04-10
Primary completion: 2027-11-30
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.